Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$432M |
| 3 |
Abbott
ABT
|
+$420M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$472M |
| 2 |
Bank of America
BAC
|
+$426M |
| 3 |
TE Connectivity
TEL
|
+$399M |
| 4 |
Atlassian
TEAM
|
+$364M |
| 5 |
Goldman Sachs
GS
|
+$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Digital Realty Trust
DLR
$59.3B
| $12.6M | 0.01% |
93,436
-5,156
| -5% | -$694K |
|
627
Perimeter Solutions
PRM
$3.22B
| $12.5M | 0.01% |
2,722,749
+9,489
| +0.3% | +$43.7K |
|
628
QuantumScape
QS
$4.73B
| $12.5M | 0.01% |
1,799,923
-33,490
| -2% | -$233K |
|
629
Yum! Brands
YUM
$40.5B
| $12.4M | 0.01% |
94,870
+21,510
| +29% | +$2.81M |
|
630
New Oriental
EDU
$9.04B
| $12.3M | 0.01% |
167,625
+46,270
| +38% | +$3.39M |
|
631
Immunocore
IMCR
$1.83B
| $12.1M | 0.01% |
+176,332
| New | +$12.1M |
|
632
Larimar Therapeutics
LRMR
$342M
| $12M | 0.01% |
2,641,065
+179,603
| +7% | +$819K |
|
633
Cameco
CCJ
$34.6B
| $12M | 0.01% |
277,140
+9,859
| +4% | +$427K |
|
634
Cigna
CI
$80.7B
| $12M | 0.01% |
40,078
-425
| -1% | -$127K |
|
|
SLRN
635
DELISTED
ACELYRIN
SLRN
| $12M | 0.01% |
1,602,155
-192,537
| -11% | -$1.44M |
|
636
CryoPort
CYRX
$480M
| $11.9M | 0.01% |
770,098
+2,724
| +0.4% | +$42.2K |
|
637
Newmont
NEM
$86.2B
| $11.9M | 0.01% |
287,146
+188,191
| +190% | +$7.79M |
|
638
ONE Gas
OGS
$4.5B
| $11.8M | 0.01% |
184,914
-42
| -0% | -$2.68K |
|
639
Becton Dickinson
BDX
$54B
| $11.7M | 0.01% |
47,814
-1,326
| -3% | -$323K |
|
640
Vishay Intertechnology
VSH
$2.07B
| $11.7M | 0.01% |
486,094
+429,346
| +757% | +$10.3M |
|
641
AT&T
T
$209B
| $11.6M | 0.01% |
692,136
-9,049
| -1% | -$152K |
|
|
FNA
642
DELISTED
Paragon 28, Inc.
FNA
| $11.5M | 0.01% |
926,742
+3,374
| +0.4% | +$41.9K |
|
643
DuPont de Nemours
DD
$31.9B
| $11.4M | 0.01% |
148,086
+52,640
| +55% | +$4.05M |
|
644
Simon Property Group
SPG
$58.5B
| $11.4M | 0.01% |
79,655
+14,011
| +21% | +$2M |
|
645
Emerson Electric
EMR
$75.2B
| $11.4M | 0.01% |
116,659
+13,712
| +13% | +$1.33M |
|
646
US Bancorp
USB
$76.6B
| $11.3M | 0.01% |
259,913
-8,193
| -3% | -$355K |
|
647
Progyny
PGNY
$1.95B
| $11.2M | 0.01% |
301,360
+14,900
| +5% | +$554K |
|
|
ALPN
648
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $11.1M | 0.01% |
+583,239
| New | +$11.1M |
|
649
Chart Industries, Inc. Depositary Shares, each Representing a 1/20th Interest in a Share of 6.75% Series B Mandatory Convertible Preferred Stock
GTLS.PRB
$570M
| $11.1M | 0.01% |
+195,956
| New | +$11.1M |
|
650
Vale
VALE
$44.8B
| $11.1M | 0.01% |
+699,564
| New | +$11.1M |
|